High fractional exhaled nitric oxide and sputum eosinophils are associated with an increased risk of future virus-induced exacerbations: A prospective cohort study - PubMed (original) (raw)
Clinical Trial
. 2017 Aug;47(8):1007-1013.
doi: 10.1111/cea.12935. Epub 2017 May 9.
Affiliations
- PMID: 28390083
- PMCID: PMC7162064
- DOI: 10.1111/cea.12935
Clinical Trial
High fractional exhaled nitric oxide and sputum eosinophils are associated with an increased risk of future virus-induced exacerbations: A prospective cohort study
A Bjerregaard et al. Clin Exp Allergy. 2017 Aug.
Abstract
Background: The major trigger of asthma exacerbations is infection with a respiratory virus, most commonly rhinovirus. Type 2 inflammation is known to be associated with an increased risk of exacerbations in general. Whether type 2 inflammation at baseline increases the risk of future virus-induced exacerbations is unknown.
Objective: To assess whether type 2 inflammation is associated with an increased risk of virus-induced exacerbations of asthma.
Methods: Stable asthmatics had spirometry, skin prick test, measurement of FeNO and sputum induced for differential cell counts. Patients were followed up for 18 months, during which they were assessed at the research unit when they had symptoms of an exacerbation. Nasal swabs collected at these assessments underwent viral detection by PCR.
Results: A total of 81 asthma patients were recruited, of which 22 (27%) experienced an exacerbation during the follow-up period. Of these, 15 (68%) had a respiratory virus detected at exacerbation. Sputum eosinophils >1% at baseline increased the risk of having a subsequent virus-induced exacerbation (HR 7.6 95% CI: 1.6-35.2, P=.010) as did having FeNO >25 ppb (HR 3.4 95% CI: 1.1-10.4, P=.033).
Conclusion and clinical relevance: Established type 2 inflammation during stable disease is a risk factor for virus-induced exacerbations in a real-life setting. Measures of type 2 inflammation, such as sputum eosinophils and FeNO, could be included in the risk assessment of patients with asthma in future studies.
Keywords: Asthma; FeNO; eosinophils; exacerbation.
© 2017 John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Figure 1
STROBE
‐chart of patients in the study
Figure 2
Respiratory viruses detected at exacerbation
Figure 3
Log‐rank test of time to exacerbation in groups based on Fe
NO
(A), sputum eosinophils (B),
ACQ
score (C) and blood eosinophils (D)
Similar articles
- Characteristics associated with clinical severity and inflammatory phenotype of naturally occurring virus-induced exacerbations of asthma in adults.
Bjerregaard A, Laing IA, Poulsen N, Backer V, Sverrild A, Fally M, Khoo SK, Barrett L, Baltic S, Thompson PJ, Chidlow G, Sikazwe C, Smith DW, Bochkov YA, Le Souëf P, Porsbjerg C. Bjerregaard A, et al. Respir Med. 2017 Feb;123:34-41. doi: 10.1016/j.rmed.2016.12.010. Epub 2016 Dec 18. Respir Med. 2017. PMID: 28137494 Free PMC article. - The Effect of Viral Infection on Exhaled Nitric Oxide in Children with Acute Asthma Exacerbations.
Malka J, Covar R, Faino A, Fish J, Pickering P, Ramamoorthy P, Gleason M, Spahn JD. Malka J, et al. J Allergy Clin Immunol Pract. 2015 Nov-Dec;3(6):913-9. doi: 10.1016/j.jaip.2015.05.029. Epub 2015 Jul 26. J Allergy Clin Immunol Pract. 2015. PMID: 26216254 Free PMC article. - Role of spirometry and exhaled nitric oxide to predict exacerbations in treated asthmatics.
Gelb AF, Flynn Taylor C, Shinar CM, Gutierrez C, Zamel N. Gelb AF, et al. Chest. 2006 Jun;129(6):1492-9. doi: 10.1378/chest.129.6.1492. Chest. 2006. PMID: 16778266 - A systematic review and meta-analysis: tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils).
Petsky HL, Cates CJ, Lasserson TJ, Li AM, Turner C, Kynaston JA, Chang AB. Petsky HL, et al. Thorax. 2012 Mar;67(3):199-208. doi: 10.1136/thx.2010.135574. Epub 2010 Oct 11. Thorax. 2012. PMID: 20937641 Review. - Recent advances in asthma biomarker research.
Leung TF, Ko FW, Wong GW. Leung TF, et al. Ther Adv Respir Dis. 2013 Oct;7(5):297-308. doi: 10.1177/1753465813496863. Epub 2013 Aug 1. Ther Adv Respir Dis. 2013. PMID: 23907809 Review.
Cited by
- Type-2 inflammation and lung function decline in chronic airway disease in the general population.
Çolak Y, Afzal S, Marott JL, Vestbo J, Nordestgaard BG, Lange P. Çolak Y, et al. Thorax. 2024 Mar 15;79(4):349-358. doi: 10.1136/thorax-2023-220972. Thorax. 2024. PMID: 38195642 Free PMC article. - Prevalence of acute infection in adults with asthma exacerbation: A systematic review and meta-analysis.
Chen X, Zhang P, Ma Y. Chen X, et al. Ann Thorac Med. 2023 Jul-Sep;18(3):132-151. doi: 10.4103/atm.atm_422_22. Epub 2023 Jul 19. Ann Thorac Med. 2023. PMID: 37663878 Free PMC article. - Resolution of Eosinophilic Pneumonia after Coronavirus Disease 2019 without Systemic Corticosteroids.
Misaki Y, Hayashi Y, Shirata M, Terada K, Yoshizawa A, Sakamoto R, Ikezoe K, Tanizawa K, Handa T, Hirai T. Misaki Y, et al. Intern Med. 2023 Nov 1;62(21):3223-3230. doi: 10.2169/internalmedicine.1648-23. Epub 2023 Aug 16. Intern Med. 2023. PMID: 37587039 Free PMC article. - A cross-sectional analysis of medical conditions and environmental factors associated with fractional exhaled nitric oxide (FeNO) in women and children from the ISA birth cohort, Costa Rica.
Werthmann D, van Wendel de Joode B, Cuffney MT, Reich BJ, Soto-Martinez ME, Corrales-Vargas A, Palomo-Cordero L, Peñaloza-Castañeda J, Hoppin JA. Werthmann D, et al. Environ Res. 2023 Sep 15;233:116449. doi: 10.1016/j.envres.2023.116449. Epub 2023 Jun 23. Environ Res. 2023. PMID: 37356534 Free PMC article. - Innate Immune Responses by Respiratory Viruses, Including Rhinovirus, During Asthma Exacerbation.
Nakagome K, Nagata M. Nakagome K, et al. Front Immunol. 2022 Jun 20;13:865973. doi: 10.3389/fimmu.2022.865973. eCollection 2022. Front Immunol. 2022. PMID: 35795686 Free PMC article. Review.
References
- Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 2015. Available from: http://www.ginasthma.org.
- Corne JM, Marshall C, Smith S, et al. Frequency, severity, and duration of rhinovirus infections in asthmatic and non‐asthmatic individuals: a longitudinal cohort study. Lancet. 2002;359:831‐834. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical